MedPath
HSA Approval

NATZO 8 TABLETS 8 mg

SIN15424P

NATZO 8 TABLETS 8 mg

NATZO 8 TABLETS 8 mg

February 9, 2018

NATCO PHARMA ASIA PTE. LTD.

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.
Licence HolderNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A04AA01

ondansetron

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Natco Pharma Limited - Pharma Division

Active Ingredients

Ondansetron Hydrochloride Dihydrate 10 mg EQV Ondansetron

8.0 mg

Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.